Ā | Vaccine recommendation following the first dose | ||||
---|---|---|---|---|---|
(1) | (2) | (3) | (4) | ||
AEFI severity (no symptom as base category) | Mild | 1.509 (0.857, 0.469) | Ā | 1.291 (0.751, 0.661) | 1.857 (1.208, 0.342) |
Moderate | 1.020 (0.631, 0.974) | Ā | 0.776 (0.503, 0.696) | 0.884 (0.648, 0.866) | |
Severe | 0.054*** (0.044,ā<ā0.001) | Ā | 0.040*** (0.035,ā<ā0.001) | 0.062** (0.070, 0.014) | |
Initial vaccine opinion (need further research as base category) | Safe and effective | Ā | 23.677*** (13.066,ā<ā0.001) | Ā | 28.658*** (16.961,ā<ā0.0001) |
Unsafe and ineffective | Ā | 0.429 (0.243, 0.136) | Ā | 0.622 (0.427, 0.490) | |
Control variables | |||||
Age (years) | Ā | Ā | 0.989 (0.020, 0.578) | 0.998 (0.021, 0.930) | |
Gender | Male | Ā | Ā | 0.550 (0.323, 0.309) | 0.486 (0.325, 0.281) |
Education status (illiterate as base category) | Primary | Ā | Ā | 0.962 (1.158, 0.974) | 0.701 (1.138, 0.827) |
Secondary | Ā | Ā | 1.250 (1.535, 0.856) | 1.339 (2.177, 0.857) | |
University | Ā | Ā | 1.945 (2.422, 0.593) | 1.975 (3.324, 0.686) | |
Occupation (government worker as base category) | Health worker | Ā | Ā | 1.074 (0.662, 0.908) | 1.208 (0.813, 0.779) |
Others | Ā | Ā | 1.648 (0.946, 0.384) | 2.362 (1.544, 0.189) | |
Constant | 23.200*** (10.597,ā<ā0.001) | 4.333*** (1.388,ā<ā0.001) | 38.221** (70.371, 0.048) | 3.319 (7.344, 0.588) | |
Observations | 602 | 602 | 602 | 602 | |
Log likelihood | āā93.245 | āā72.012 | āā91.501 | āā65.245 | |
Akaike Inf. Crit. | 194.489 | 150.02 | 205.002 | 156.489 |